Express Scripts Holding Company

    Express Scripts Holding Company

    NNASDAQ:ESRX
    - -
    USD
    - -
    - -
    10.92P/E
    2005 Y
    2006 Y
    2007 Y
    2008 Y
    2009 Y
    2010 Y
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    TTM
    Revenue per Share
    27.66
    31.58
    35.09
    44.15
    46.96
    83.52
    92.09
    128.34
    128.74
    134.46
    147.68
    159.97
    172.5
    179.98
    Basic EPS, GAAP
    0.68
    0.85
    1.09
    1.56
    1.57
    2.19
    2.55
    1.8
    2.28
    2.68
    3.59
    5.43
    7.79
    8.7
    Free Cash Flow per Basic Share
    1.25
    1.06
    1.44
    2.04
    3.08
    3.71
    4.09
    6.32
    5.36
    5.48
    6.61
    7.32
    9.22
    7.74
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    2.63
    3.61
    4.97
    6.76
    7.95
    9.98
    13.28
    2.84
    4.85
    7.9
    12.2
    18.84
    28.15
    33.56
    Tangible Book Value per Share
    -2.62
    -3.47
    -4.49
    -4.29
    -7.31
    -6.69
    -9.25
    -30.09
    -26.56
    -28.62
    -32.46
    -34.57
    -38.96
    -33.67
    Basic Weighted Avg Shares
    588
    559
    521
    498
    527
    539
    501
    731
    809
    750
    689
    627
    580
    563
    Sales/Revenue/Turnover
    16,266
    17,660
    18,274
    21,978
    24,749
    44,973
    46,128
    93,858
    104,099
    100,887
    101,752
    100,288
    100,065
    101,353
    Operating Margin (%)
    3.95
    4.67
    5.81
    5.83
    6.05
    4.6
    5.01
    2.97
    3.41
    3.57
    4.26
    5.07
    5.49
    5.27
    Depreciation Expense
    95
    101
    98
    98
    110
    245
    253
    1,873
    2,447
    2,243
    2,359
    2,155
    1,802
    1,958
    Net Income, GAAP
    400
    474
    568
    776
    828
    1,181
    1,276
    1,313
    1,845
    2,008
    2,476
    3,404
    4,517
    4,900
    Effective Tax Rate (%)
    34.96
    35.94
    36.45
    35.76
    36.87
    36.89
    36.98
    38.03
    36.43
    33.63
    35.31
    22.58
    8.06
    68.95
    Profit Margin (%)
    2.46
    2.69
    3.11
    3.53
    3.34
    2.63
    2.77
    1.4
    1.77
    1.99
    2.43
    3.39
    4.51
    4.83
    Working Capital
    -137
    -657
    -507
    -678
    -1,313
    -976
    2,600
    -2,300
    -4,744
    -6,449
    -5,096
    -4,065
    -5,889
    -4,339
    LT Debt
    1,401
    1,270
    1,760
    1,340
    2,493
    2,494
    7,076
    14,980
    12,363
    11,013
    13,946
    14,846
    14,982
    12,974
    Total Equity
    1,465
    1,125
    696
    1,078
    3,552
    3,607
    2,474
    23,396
    21,845
    20,064
    17,381
    16,244
    18,125
    20,573
    Return on Invested Capital (%)
    18.16
    19.02
    25.48
    29.61
    18.5
    19.38
    17.5
    6.92
    6.01
    6.89
    8.43
    12.16
    15.32
    - -
    Return on Capital (%)
    17.26
    14.54
    14.06
    16.97
    14.45
    16.19
    12.96
    10.26
    12.24
    12.66
    12.76
    15.25
    16.95
    46.55
    Return on Common Equity (%)
    29.76
    26.62
    24.65
    26.08
    21.9
    24.69
    21.21
    30.08
    61.51
    40.76
    34.55
    33.68
    32.11
    29.79

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'18
    Jun'18
    Sep'18
    ST Debt
    86
    1,533
    2,021
    LT Borrowings
    14,901
    13,458
    12,974
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    562
    562
    564
    Market Capitalization
    39,419
    43,653
    53,505

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'18
    Jun'18
    Sep'18
    Total Current Assets
    11,475
    13,170
    14,352
    Cash, Cash Equivalents & STI
    2,318
    2,942
    3,706
    Accounts Receivable, Net
    6,794
    4,105
    4,070
    Inventories
    2,028
    2,293
    2,169
    Total Current Liabilities
    16,723
    18,587
    18,691
    Payables & Accruals
    16,638
    17,054
    16,670
    ST Debt
    86
    1,533
    2,021
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    107.7%
    -4.62%
    11.58%
    Free Cash Flow
    26.28%
    3.36%
    16.61%
    Net Income, GAAP
    23.98%
    28.57%
    32.69%
    Sales/Revenue/Turnover
    22.77%
    1.4%
    -0.22%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2016
    24,792
    25,222
    25,410
    24,863
    100,288
    2017
    24,655
    25,348
    24,683
    25,379
    100,065
    2018
    24,769
    25,642
    25,563
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2016
    0.82
    1.14
    1.16
    2.36
    5.43
    2017
    0.91
    1.38
    1.47
    4.12
    7.79
    2018
    1.11
    1.56
    1.9
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2016
    - -
    - -
    - -
    - -
    - -
    2017
    - -
    - -
    - -
    - -
    - -
    2018
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • nypost.com

      UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices